Safety Both medicines have been found in trials to be safe for weight loss treatment, including in the long-term
It curbs appetite, helps control blood sugar, and slows digestion so you stay satisfied longer
Originally formulated for patients with diabetes, GLP-1 receptor agonist medications were FDA approved in 2022 for weight loss
Combining Treatments: Compounding also allows for combining Tirzepatide with other medications or treatments, which can be particularly useful for patients dealing with multiple conditions
Traditional weight loss medications, including orlistat and phentermine, also carry risks of significant hair loss, though through different mechanismsorlistat by reducing fat-soluble vitamin absorption and phentermine through metabolic stress responses
Noom Med starts at $129 per month but can increase to $279 in subsequent months